Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma.

Zuyuan Lin,Huigang Li,Chiyu He,Modan Yang,Hao Chen,Xinyu Yang,Jianyong Zhuo,Wei Shen,Zhihang Hu,Linhui Pan,Xuyong Wei,Di Lu,Shusen Zheng,Xiao Xu

Frontiers in oncology（2023）

引用 3|浏览8

暂无评分

摘要

The established three-marker model and nomogram based on metabolomic profiling can be potential non-invasive tool for the diagnosis of AFP negative HCC. The level of MG(18:2/0:0/0:0) exhibits good prognosis prediction performance for AFP negative HCC.

查看译文

关键词

AFP,cirrhosis,hepatocellular carcinoma,metabolomics,nomogram

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要